An MGA does not supervise an independent authorised broker in the same way that an FCA principal supervises an Appointed Representative. The broker has its own regulatory responsibilities and remains an independent firm, but that does not mean the MGA can treat distribution as a purely commercial relationship. Where the MGA manufactures or distributes insurance products, PROD 4, Consumer Duty where applicable, fair value and the firm's wider systems and controls can require meaningful information and oversight across the distribution chain.
The purpose of broker oversight is therefore narrower and more precise than principal and AR oversight. The MGA needs enough information to determine whether the broker remains an appropriate distribution channel, whether the product is reaching its intended target market, whether remuneration or additional charges are affecting fair value, and whether actual customer outcomes indicate that the product or distribution strategy needs to change.
For MGAs with large broker populations, this can become a significant governance exercise. A signed TOBA, an FCA Register check and an annual questionnaire may be useful controls, but they do not by themselves tell management how the product is being distributed or whether one broker is producing materially different customer outcomes from the rest of the portfolio.
Define the regulatory purpose of the oversight first
The oversight framework should start with the MGA's own regulatory responsibilities rather than an assumption that every broker needs the same due diligence pack. The questions the MGA needs to answer will depend on whether it is acting as manufacturer, co-manufacturer or distributor and on the nature of the product being sold.
For a manufacturer, broker oversight is closely connected to the intended distribution strategy, target market and fair value assessment. The firm should be able to demonstrate why the chosen distribution channels are appropriate for the product and should obtain enough information to identify whether the product is reaching customers outside its intended market or whether the distribution arrangements are negatively affecting value.
Where the MGA acts as distributor, PROD 4.3 requires appropriate product distribution arrangements, including sufficient information about the product, target market and value assessment. The MGA's oversight of downstream brokers should therefore support its own distribution responsibilities rather than replicate controls that belong to the product manufacturer.
The distinction from Appointed Representative oversight should remain clear throughout. An independent broker should not be treated contractually or operationally as though it is part of the MGA's AR network unless that is the actual legal relationship. The oversight should be proportionate to what the MGA needs to know and control to discharge its own regulatory duties.
Onboarding should test product and channel compatibility
Broker onboarding should go beyond confirming that the firm appears on the Financial Services Register. Regulatory status is essential, but the MGA should also understand whether the broker's business model, customer population, expertise and distribution method are compatible with the products it will distribute.
A specialist product designed for a narrow customer group may require brokers with particular technical knowledge or access to a defined market. A simpler product may support broader distribution. The key is that broker selection should follow the product's target market and intended distribution strategy rather than the commercial opportunity alone.
The onboarding process should also identify relevant risks in the broker's service model. Customer fees, premium finance, delegated activities, reliance on lead generators or unusual pricing discretion can each affect the final customer proposition. The existence of these features does not make the broker unsuitable, but the MGA should understand them before deciding what information and monitoring will be required.
Due diligence should remain proportionate. The objective is not to collect the largest possible set of documents from every broker, but to obtain enough evidence to make a reasoned decision about whether the broker is an appropriate distribution channel and how it should be risk rated at the outset.
Product and target-market information must move both ways
A manufacturer should provide distributors with enough information to understand the product and the customers for whom it has been designed. A target-market statement that remains inside the MGA's product governance file does not help the broker make appropriate distribution decisions, so the firm should consider whether product information is written in a form that distributors can use operationally.
The flow also needs to work in reverse. Brokers may hold information the MGA needs to understand whether the product is being distributed as intended, including customer mix, target-market exceptions, complaints, cancellation patterns, fees, premium finance usage and other relevant outcomes. The appropriate information will vary by product and channel, so the framework should be driven by the questions management needs to answer rather than a standard data request used for every relationship.
Information quality matters as much as availability. If a broker repeatedly submits incomplete or inconsistent data, the MGA should understand whether that weakness affects its ability to perform product review or fair value analysis. A contractual right to request information is not an effective control if persistent data gaps have no consequence.
The strongest arrangements establish a predictable rhythm for information exchange while preserving the ability to request additional information when a trigger occurs. This avoids both extremes: collecting large quantities of data that nobody uses and relying entirely on ad hoc requests after a problem has already become visible.
Fair value makes remuneration and customer pricing relevant
Broker remuneration is one of the clearest areas where product governance and commercial distribution overlap. Under PROD, relevant distributors must understand the impact their distribution arrangements, including remuneration, have on overall product value, while manufacturers need sufficient information to assess whether the distribution channel continues to result in fair value for customers in the target market.
This does not create a universal commission cap and does not mean every difference in remuneration is problematic. The MGA should understand what services or benefits are provided through the channel and whether the additional cost has a reasonable relationship with the value added. A specialist broker providing substantial advice and servicing can present a different value proposition from a channel adding significant cost while providing little additional customer benefit.
Pricing discretion deserves similar attention. Where the broker can influence the final customer price, the MGA should understand whether actual pricing remains consistent with the manufacturer's value assessment. Material differences between comparable brokers or customer groups should be investigated rather than averaged away.
Premium finance and ancillary products may also affect the final proposition. Where they are material to the distribution model, the oversight framework should obtain enough information to understand their effect on customer value and whether the relevant distributor responsibilities are being met.
Risk-rate brokers using evidence that can change over time
A useful broker risk framework should distinguish between relationships rather than placing every distributor in the same monitoring cycle. Relevant factors may include product complexity, business volume, customer type, pricing discretion, complaints, target-market exceptions, previous findings, rapid growth, data quality and the degree of reliance the MGA places on the broker for customer information.
The initial rating should influence the level of oversight. A higher-risk broker may justify more frequent data review, direct meetings, sample testing or focused review of pricing and customer outcomes, while a stable lower-risk relationship may support a lighter approach. The important point is that the rating changes what the MGA actually does.
Risk ratings should also be dynamic. Rapid growth, a change in ownership, materially higher complaints or a shift into new customer segments can alter the risk profile even where the broker was considered low risk at onboarding. A framework in which broker ratings rarely change can indicate that the methodology is not responding to live evidence.
Management should be able to explain why the highest-risk brokers are rated that way and what additional controls follow. If the risk score exists only to populate a dashboard, it provides limited regulatory value.
Use complaints, claims and file testing to identify outliers
Complaint data can be one of the most useful broker oversight tools when it is analysed properly. Raw counts can be misleading because larger brokers naturally generate more cases, so the MGA should consider rates, root causes and recurring themes where relevant to the product.
Claims information can also reveal distribution differences. A materially different acceptance rate, recurring dispute about a particular exclusion or higher levels of customer confusion through one broker may justify investigation, although it should not be assumed automatically that the broker has acted improperly. Customer mix, product use and other legitimate factors can explain differences, which is why the purpose of MI is to identify questions rather than substitute for analysis.
Targeted file testing can then provide deeper assurance. The sample should follow the risk identified through MI rather than be selected only for convenience. Reviewing higher-fee transactions, target-market exceptions, complaints or business from a rapidly growing broker can produce more useful evidence than a random sample dominated by routine cases.
The results should feed back into both broker oversight and product governance. A distribution issue that repeatedly affects the same product may indicate that the product information, target market or design requires attention rather than only the individual broker relationship.
TOBAs should support oversight, not replace it
The inter-firm TOBA or agency agreement should provide the contractual foundation for the relationship. It can define regulatory status, authority, information requirements, remuneration, money handling, complaints cooperation, audit rights and termination, but none of those provisions performs the oversight by itself.
The MGA should know which contractual rights it actually relies upon. If product governance requires remuneration or customer outcome information, the agreement should support access to that information. If the MGA has an audit right, there should be a methodology for deciding when deeper review is required rather than leaving the clause unused indefinitely.
The agreement should also stay aligned with operational practice. Broker relationships evolve as new products are added, pricing discretion changes or information requirements develop, and a legacy TOBA can eventually describe a relationship that no longer exists. Periodic regulatory review should therefore compare the agreement with the actual distribution model.
Article 9 in this series deals specifically with the regulatory review of insurance TOBAs and broker agency agreements, including CASS and risk-transfer wording where relevant.
Escalation should be proportionate and capable of changing the channel
Oversight needs a defined response when the evidence is poor. The first step may be clarification, additional information or targeted review, but more material concerns can require enhanced monitoring, restrictions on a product, changes to pricing or remuneration, customer remediation or termination of the relationship.
The response should be linked to the MGA's own regulatory responsibility. Under PROD, where distribution is detrimentally affecting intended value, manufacturers must take appropriate remedial measures, which can include changing distribution arrangements or remuneration and ceasing to use particular distributors or channels. That means serious value concerns cannot remain indefinitely in a broker action log without affecting the product's route to market.
Not every control failure warrants a severe commercial response. Proportionality remains important, and the MGA should distinguish an isolated administrative error from a recurring issue capable of causing customer harm. The governance record should explain what was found, why the selected response was appropriate and what evidence will demonstrate improvement.
Good broker oversight therefore does not mean controlling an independent intermediary's entire business. It means maintaining enough visibility and contractual leverage to discharge the MGA's own regulatory responsibilities and being prepared to change the distribution arrangement when the evidence requires it.
How Regulatory Counsel can support
Regulatory Counsel supports MGAs with broker onboarding, risk segmentation, PROD 4 distribution governance, fair value, remuneration, TOBA review, management information, thematic testing and remediation. Reviews can cover the complete broker oversight framework or focus on a particular product, distribution channel or higher-risk broker population.
Speak to Regulatory Counsel to discuss broker oversight for an MGA.
Frequently Asked Questions
No. An independent authorised broker has its own regulatory responsibilities. The MGA nevertheless needs sufficient oversight and information where this is necessary to meet its own product governance, fair value, Consumer Duty or other regulatory obligations.
For relevant products, remuneration can be directly relevant to fair value. The manufacturer needs enough information to understand how distribution arrangements affect overall product value, while the distributor must consider the relationship between its remuneration, services and the value provided to customers.
There is no single FCA timetable for every independent broker relationship. Oversight should reflect the risk of the product and channel and should become more intensive when evidence such as complaints, growth, pricing or data quality indicates higher risk.
Targeted file testing can be appropriate where it provides evidence the MGA needs to discharge its own regulatory responsibilities. The scope should follow the relationship and risk rather than treating the independent broker as though it were an Appointed Representative.
The MGA should investigate the cause and take proportionate action. Where distribution is detrimentally affecting intended value, PROD can require remedial measures including changes to remuneration or distribution arrangements and, where necessary, ceasing to use a particular distributor or channel.